Amgen (NASDAQ:AMGN) Releases FY 2025 Earnings Guidance

Amgen (NASDAQ:AMGN) updated its FY 2025 earnings guidance. The company provided EPS guidance of 20.000-21.200 for the period, compared to the consensus estimate of 20.820. The company also issued revenue guidance of $34.3 billionillion-$35.7 billionillion, compared to the consensus estimate of $34.5 billionillion.